Showing results (661-670 of 1,561) with videos related to
Sort By:
Pageof 157
Expert Review of Hematology|September 29, 2016
Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan AfricaHalima Bello-Manga, Michael R DeBaun, Adetola A KassimExpert Review of Hematology|April 16, 2020
Current approaches in the treatment of catheter-related deep venous thrombosis in childrenJulie Jaffray, Neil GoldenbergExpert Review of Hematology|April 15, 2020
Advances in managing rare acquired bleeding disordersMassimo Franchini, Giuseppe Marano, Mario Cruciani, et al.Expert Review of Hematology|May 9, 2015
Lenalidomide for mantle cell lymphomaAlan P Skarbnik, Andre H GoyExpert Review of Hematology|February 9, 2026
Real-world treatment switching and sequencing to next line of therapy of zanubrutinib, acalabrutinib, and ibrutinib in chronic lymphocytic leukemia or small lymphocytic lymphomaJavier Pinilla-Ibarz, Mei Xue, Elizabeth Wu, et al.Expert Review of Hematology|February 10, 2026
Real-world treatment utilization patterns, discontinuation and healthcare resource utilization of first-line Bruton tyrosine kinase inhibitors among elderly patients ≥65 years in chronic lymphocytic leukemiaSikander Ailawadhi, Swetha Challagulla, Po-Ya Chuang, et al.Expert Review of Hematology|January 21, 2026
Feasibility and outcomes of switching factor VIII therapies: post-hoc analysis of patients transitioning from older plasma-derived and first-generation recombinant factor VIII to newer third generation recombinant factor VIII replacement therapies within the Takeda factor VIII portfolioAlicia Cerretani, Ian Robinson, Jonathan Shtaynberger, et al.Expert Review of Hematology|December 29, 2025
Addressing unmet needs in chronic myeloid leukemia in chronic phase treated with two or more tyrosine kinase inhibitors: insights from literature and Indian clinical practiceArijit Nag, Vishnu Sharma, Sadashivudu Gundeti, et al.Expert Review of Hematology|January 7, 2026
Comparison of restrictive and liberal blood transfusion in critically ill adults: a meta-analysis and comprehensive reviewXinying Quan, Yao Pu, Keming XiaExpert Review of Hematology|August 20, 2016
Reappraising the timing of transplant for indolent non-Hodgkin lymphomasSaveria Capria, Walter Barberi, Salvatore Perrone, et al.Pageof 157